Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MK-1308A |
Synonyms | |
Therapy Description |
MK-1308A is a coformulation of Pembrolizumab and Quavonlimab, which potentially induces antitumor activity (Cancer Res (2024) 84 (7_Supplement): CT256). |